Abstract
Patients with amyloidosis have decreased survival, unless novel disease modifying therapies are introduced. Early diagnosis improves survival and identification of at-risk populations is critical to improve outcomes. The epidemiology of amyloidosis in the US Veterans Health Administration is unknown. The objective of this project is to calculate the incidence of amyloidosis in the US Veterans Health Administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.